Skip to main content

Clinically avoidable denials continue to impact revenue, slow cashflow and increase bad debt, yet CFOs have limited insight into why these denials occur and how to avoid them. Half of healthcare organizations hold more than 3% of total net patient revenue (NPR) in reserves each fiscal year in anticipation of denials claims, with over a third holding back greater than 5%. However, less than a quarter of organizations track trends related to clinically avoidable denials.

Dawn Crump, MA, CHC, SSBB

As Senior Director of Revenue Cycle Solutions for MRO, Crump oversees revenue cycle and business office specific solutions. She has over 25 years as an experienced healthcare leader with extensive knowledge of provider compliance and revenue cycle operations. She has held leadership roles in large health systems, small revenue cycle startups and in a value-based care technology company, where she managed quality and compliance. Crump has a passion for improving healthcare and reducing administrative burdens, especially across revenue cycle functions and payer audits. She has spoken at numerous HCCA, AHIMA and HFMA events, and is a national author on compliance and revenue cycle topics. She attended University of Missouri- Columbia, and currently serves as secretary of the Greater Heartland HFMA chapter.

More Posts